Overview Chemomab is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet needs. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory di...
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2023-03-20 | 2022-12-31 | 0001178913-23-001041 | EDGAR | 80K words |
| 2022-03-30 | 2021-12-31 | 0001178913-22-001304 | EDGAR | — |
| 2021-03-09 | 2020-12-31 | 0001104659-21-033822 | EDGAR | — |
| 2020-03-17 | 2019-12-31 | 0001104659-20-034835 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2023-05-11 | 2023-03-31 | 0001178913-23-001807 | EDGAR | 10K words |
| 2022-11-10 | 2022-09-30 | 0001178913-22-003931 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001178913-22-003074 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001178913-22-001919 | EDGAR | — |
| 2021-11-12 | 2021-09-30 | 0001178913-21-003509 | EDGAR | — |
| 2021-08-13 | 2021-06-30 | 0001178913-21-002696 | EDGAR | — |
| 2021-05-13 | 2021-03-31 | 0001104659-21-065588 | EDGAR | — |
| 2020-11-16 | 2020-09-30 | 0001104659-20-125523 | EDGAR | — |
| 2020-08-14 | 2020-06-30 | 0001104659-20-095149 | EDGAR | — |
| 2020-05-07 | 2020-03-31 | 0001104659-20-058143 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2023-06-16 | 0001178913-23-002225 | EDGAR | 1K words |
| 2023-06-05 | 0001178913-23-002136 | EDGAR | — |
| 2023-05-11 | 0001178913-23-001809 | EDGAR | — |
| 2023-02-21 | 0001178913-23-000679 | EDGAR | — |
| 2023-02-21 | 0001178913-23-000670 | EDGAR | — |
| 2023-01-11 | 0001178913-23-000147 | EDGAR | — |
| 2023-01-03 | 0001178913-23-000010 | EDGAR | — |
| 2022-11-16 | 0001178913-22-004061 | EDGAR | — |
| 2022-11-14 | 0001178913-22-004019 | EDGAR | — |
| 2022-08-12 | 0001178913-22-003072 | EDGAR | — |
142 total filings indexed. 118 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001534248 |
| Ticker | CMMB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L3 |
| Website | https://www.chemomab.com |
| Listed | 2021-03-17 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CMMB (~200 tokens, structured JSON with cryptographic provenance)